Patents Assigned to Antibiotics, S.A.
  • Patent number: 6815189
    Abstract: An isolated DNA sequence that encodes a peptide with CPC-acetylhydrolase enzymatic activity is disclosed. Also, a method of expressing CPC-acetylhydrolase activity that includes the steps of (a) providing a microorganism that is susceptible to transformation with the isolated DNA sequence and that, upon transformation, expresses the CPC-acetylhydrolase activity encoded by the sequence, and (b) transforming the microorganism with the DNA sequence to cause expression of the CPC-acetylhydrolase activity in the microorganism is disclosed. Also, a method for producing a microorganism with increased capacity to aid in the production of cephalosporin, which method includes the steps of (a) providing a microorganism that has CPC-AH activity by virtue of expression of the DNA sequence or of a fragment thereof coding for the CPC-acetylhydrolase enzyme activity; and (b) inactivating the activity by disrupting expression of the DNA sequence is disclosed.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: November 9, 2004
    Assignee: Antibiotics, S.A.U.
    Inventors: Javier Velasco Alvarez, Santiago Gutierrez Martin, Francisco Javier Casqueiro Blanco, Sonia Campoy Garcia, Francisco Fierro Fierro, Jose Luis Barredo Fuente, Bruno Diez Garcia, Juan Francisco Martin Martin
  • Patent number: 6187574
    Abstract: Process for producing the enzyme D-amino acid oxydase of Rhodotorula gracilis in host cells. The process for the expression of the enzyme comprises isolating the complementary DNA corresponding to the messager RNA of the gene which codes for the D-amino acid oxydase of any strain of Rhodotorula gracillis producing said enzyme; fusing the fragment of DNA which codes for D-amino acid oxydase of Rhodotorula gracillis with a DNA sequence which contains a site of union to the ribosome and a high efficiency promoter sequence for the express of genes in host cells; inserting the DNA fragment into a plasmid appropriate for the host cell; cultivating the host cells transformed with said plasmid; and collecting the enzyme.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: February 13, 2001
    Assignee: Antibiotics, S.A.
    Inventors: Jose Luis Garcia Lopez, Estrella Cortes Rubio, Jorge Alonso Palacios, Jose Luis Barredo Fuente, Bruno Diez Garcia, Miguel Angel Moreno Valle, Carmen Schleissner Sanchez, Alfonso Collados de la Vieja, Alejandro Vitaller Alba, Francisco Salto Maldonado
  • Patent number: 4959327
    Abstract: Disclosed is a method for transforming Penicillium chrysogenum. More particularly, the method includes obtaining an auxotrophic mutant of P. chrysogenum and employing an exogeneous segment of P. chrysogenum DNA capable of complementing said auxotorph so as to restore prototrophy. The exogeneous DNA segment thus comprises a phenotypic marker indicating successful transformation of the mutant.The exogeneous complementary DNA segment may further be prepared in a recombinant plasmid vector. These plasmid vectors include, by way of example, the pPctrpCL and pPctrpC.sub.6 plasmids developed by Applicants. These transforming plasmid vectors and those having identifying characteristics thereof are suitable for use in the subject transformation process. The exogeneous complementary DNA segment comprises a gene encoding a selected biosynthetic enzyme. By way of example, these genes include trpC, pyr4, argB and NO.sup.- reductase, as well as other genes which encode metabolically required enzymes.
    Type: Grant
    Filed: February 2, 1987
    Date of Patent: September 25, 1990
    Assignee: Antibiotics, S.A.
    Inventors: Florentina S. Sanchez, Victor R. Susan, Miguel A. P. Soto, Agustin P. A. Ortega
  • Patent number: 4232162
    Abstract: The present invention is related to a process in which an oxazolidinone is reacted with phosphorus pentachloride and the resulting mixture is reacted with a nucleophilic agent in an inert solvent to give P-substituted N,N'-bis-(3-oxazolidinyl-2-one)phosphoramides having the general formula ##STR1## where R.sub.1, R.sub.2, R.sub.3, R.sub.4 are each a group selected from among hydrogen, C.sub.1 -C.sub.4 alkyls or an aromatic nucleus and X is a group which may be introduced by nucleophilic substitution. The invention is also related to the compounds thus obtained.
    Type: Grant
    Filed: July 24, 1978
    Date of Patent: November 4, 1980
    Assignee: Antibiotics, S.A.
    Inventors: Antonio L. P. Coll, Jose D. Meseguer